301290.SZ · 东星医疗
China A-shares · RS rating 69 · As of 2026-10-14
| Price | 26.28 CNY |
|---|---|
| 1-day change | -3.3% |
| RS rating (overall / 1M / 3M / 12M) | 69 / 43 / 48 / 70 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 26 / 22 / 16 |
| Industry group (rank) | Medical-Products (64) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -0.7% |
| Distance from 52-week high | +26.8% |
| Market cap (USD) | $421.1M |